Location/Division Specific Information:
Olink, part of Thermo Fisher Scientific, is dedicated to advancing the understanding of human disease through proteomics. Olink panels provide innovative, high-quality solutions for human protein biomarker discovery, enabling researchers to measure thousands of proteins simultaneously from just a few microliters of blood. Using highly specific and thoroughly validated assays with a wide dynamic range, Olink’s technology overcomes traditional limitations in protein analysis and supports deeper insights into human biology and disease.
Assay Development NGS, in the Highplex department within RnD, has the main responsibility to develop immunoassays for Olink's Highplex products and to evaluate assay performance throughout development projects. The team is highly involved in new product introduction projects (“NPI projects), which are carried out with members from other departments.
We are now looking to hire an R&D Tech Lead who is responsible for leading product design and development activities within a cross-functional NPI project team in accordance with the Thermo Fisher Project Commercialization model. The role ensures that customer requirements are translated into robust product requirementsand that design outputs meet defined specifications, timelines, and quality standards.
Drive the execution, coordination, and integration of product design activities performed by the R&D Extended team, ensuring timely and high-quality deliverables.
At Olink, Thermo Fisher Scientific, you will be part of a nurturing team that values integrity, innovation, and involvement. We offer an encouraging environment where your diverse experiences and perspectives are appreciated, enabling you to thrive and excel in your career. Come aboard and contribute significantly to global health and safety!
If you believe you’re the right fit for this role, we encourage you to submit your resume along with a cover letter highlighting your relevant experience. The last day for applications is on the 24th of May 2026.
